Tuesday, February 26, 2019 1:23:45 PM
There was a run up in the weeks leading up to legalization for most of the MJ companies, but unfortunately that is not what I am talking about, I am talking about what the prices were like a year ago.
On the TSX, a year ago:
CRON was trading between $9 and $13 CAD...it is now trading between $27 and $30 CAD (Up)
CGC was trading between $35 and $40 CAD...it is now trading around $60 CAD (Up)
HEXO was trading between $3.50 and $4.00 CAD...it is now trading around $7.50 CAD (Up)
ACB was trading between $12 - $15 CAD...it is now trading trading between $8 - $10 CAD (DOWN BIG TIME). Nice going ACB!
I am talking about a year ago here, but most of these companies (except for ACB) have returned to close to their highs (or better).
I find it highly unlikely that ACB will be profitable next quarter. For the latest quarter, they had $54 million in net revenue (sales). And they posted a $240 million loss, of which $190 million was attributed to write-downs (which i expect to see in the future as well). So excluding the write down, they posted a $50 million dollar loss on $54 million in revenue. That's a pretty big hole they are going to have to climb out of to be profitable.
On the TSX, a year ago:
CRON was trading between $9 and $13 CAD...it is now trading between $27 and $30 CAD (Up)
CGC was trading between $35 and $40 CAD...it is now trading around $60 CAD (Up)
HEXO was trading between $3.50 and $4.00 CAD...it is now trading around $7.50 CAD (Up)
ACB was trading between $12 - $15 CAD...it is now trading trading between $8 - $10 CAD (DOWN BIG TIME). Nice going ACB!
I am talking about a year ago here, but most of these companies (except for ACB) have returned to close to their highs (or better).
I find it highly unlikely that ACB will be profitable next quarter. For the latest quarter, they had $54 million in net revenue (sales). And they posted a $240 million loss, of which $190 million was attributed to write-downs (which i expect to see in the future as well). So excluding the write down, they posted a $50 million dollar loss on $54 million in revenue. That's a pretty big hole they are going to have to climb out of to be profitable.
Recent ACB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2026 12:44:17 PM
- Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science • PR Newswire (Canada) • 05/14/2026 10:54:00 AM
- Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science • PR Newswire (US) • 05/14/2026 10:54:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2026 12:15:03 PM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (US) • 04/28/2026 10:53:00 AM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (Canada) • 04/28/2026 10:53:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2026 08:18:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2026 11:21:53 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (US) • 04/15/2026 11:05:00 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (Canada) • 04/15/2026 11:05:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/30/2026 11:29:57 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (US) • 03/30/2026 11:03:00 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (Canada) • 03/30/2026 11:03:00 AM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (Canada) • 02/17/2026 11:39:00 PM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (US) • 02/17/2026 11:39:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 09:26:03 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (Canada) • 02/12/2026 09:05:00 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (US) • 02/12/2026 09:05:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (Canada) • 02/11/2026 12:00:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (US) • 02/11/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 09:44:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 02:45:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:27:19 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 02/04/2026 12:10:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:05:38 PM
